Colleges
-
Novel Intraoperative Imaging Device Advances Precision Surgery for Patients with Cancer
The Dynamic Optical Contrast Imaging (DOCI) device is a revolutionary, non-invasive imaging system that utilizes advanced high-speed cameras and LED lights to delineate margins between malignant and healthy tissue in real-time. This pioneering imaging device, created by a UCLA Health surgeon, does not require the use of injectables or dyes like traditional cancer-identifying devices. The DOCI system was created by…
Read More » -
Why are more young people getting cancer? What to know as cases rise
It’s a mystery doctors and scientists have yet to solve: More younger adults are getting diagnosed with cancer. The number of early onset cancer cases — those that occur in adults under age 50 — is rising by 1% to 2% annually, according to the American Cancer Society. An analysis of global health data published in the journal BMJ Oncology predicts…
Read More » -
UCLA Health launches clinical trial using personalized cancer vaccine to tackle aggressive brain tumors in adolescents and young adults
UCLA Health is leading a groundbreaking clinical trial to combat one of the most aggressive forms of brain cancer with a personalized cancer vaccine. This pioneering study represents UCLA Health’s inaugural human trial for a vaccine specifically targeting diffuse hemispheric glioma, a malignant brain tumor predominantly affecting adolescents and young adults. The trial, funded by the Department of Defense, the…
Read More » -
‘A one-and-done treatment’: UChicago Medicine among the first in the U.S. to use TIL therapy for advanced skin cancer
For 15 years, Alla Pinzour traveled the country seeking treatments for her advanced melanoma. Some would bring temporary remission, but her skin cancer always returned. “Surgeries, chemo, radiation — you name it, I had it done,” she said. “Nothing seemed to work.” By early 2024, Pinzour’s skin cancer had spread to other places in her body, including her lungs and…
Read More » -
WCM-Q to host second alumni-led primary care conference
Weill Cornell Medicine-Qatar (WCM-Q) will host its second annual Updates in Primary Care conference on November 29 and 30 in Doha, Qatar. The conference, titled ‘Updates in Primary Care: Specialist-Led Case-Based Discussions Highlighting the Latest Evidence and Best Clinical Practice – 2024,’ reflects WCM-Q’s commitment to delivering cutting-edge, practical education. Organized entirely by graduates of the college, the two-day conference…
Read More » -
Theranostics treatments for cancer underway at UCLA Health
UCLA Health’s new leading-edge theranostics center, using targeted radioactive drugs to treat advanced cancer, is now open. Offering state-of-the-art facilities and expertise, the 3,000-square-foot Outpatient Theranostics Center in Westwood, part of the UCLA Health Jonsson Comprehensive Cancer Center, specializes in radiopharmaceutical therapy. It is one of the largest of its kind in the United States, according to Jeremie Calais, MD,…
Read More » -
Ghaith Abu-Zeinah, M.D.
Assistant Professor of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York Assistant Attending Physician, NewYork-Presbyterian Hospital Visiting Faculty Member, Weill Cornell Medicine-Qatar “The general symptoms of MPNs include fatigue, headaches, weight loss, and night sweats.” Dr. Ghaith Abu-Zeinah is an Assistant Professor of Medicine in the Division of Hematology and Oncology at Weill Cornell Medicine in New…
Read More » -
UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies
The University of Chicago Medicine Comer Children’s Hospital will be among the first in the country to offer gene therapy for sickle cell disease in patients 12 years and older, after federal regulators approved two new treatments on December 8, 2023. Thousands of patients with sickle cell disease experience complications including anemia, vaso-occlusive crises (VOCs), acute chest syndrome (ACS) and…
Read More » -
WCM-Q students probe the effects of weight loss drugs on diabetes, obesity and cancer
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a study that delves into the effects of Ozempic-type drugs on the interconnected health challenges of obesity, diabetes, and cancer. Ozempic, the brand name of a drug called semaglutide, belongs to a class of medications called glucagon-like peptide-1 receptor (GLP-1R) agonists. These medications have…
Read More » -
An Open Health Day for Mount Lebanon Hospital University Medical Center (MLHUMC) in collaboration with Balamand University
An Open Health Day for Mount Lebanon Hospital University Medical Center (MLHUMC) in collaboration with Balamand University A unique initiative that combines treatment to research in presence of top-notch specialists Small signs might be an alarm to overlaying more serious health issues. In this perspective, Mount Lebanon Hospital University Medical Center (MLHUMC) organized together with Balamand University in Dekwaneh, an…
Read More »